A multimorbilidade e o desafio de um atendimento médico significativo e personalizado: editorial by Heleno, Bruno & Silvério-Rodrigues, David
Editorial
Port J Public Health 2019;37:I–III
Multimorbidity and the Challenge to 
Deliver Personalised and Meaningful 
Health Care
Bruno Heleno a, b    David Silvério-Rodrigues a, c    
a
 Faculdade de Ciências Médicas, NOVA Medical School, Comprehensive Health Research Centre, Lisbon, Portugal; 
b
 ACES Lisboa Norte, Lisbon, Portugal; c CUF Torres Vedras, Torres Vedras, Portugal
Published online: August 6, 2019
Bruno Heleno
NOVA Medical School, Universidade NOVA de Lisboa
Rua do Inst. Bacteriológico
PT–1150-190 Lisbon (Portugal)
E-Mail bruno.heleno @ nms.unl.pt
© 2019 The Author(s) Published by S. Karger AG, Basel 




A multimorbilidade e o desafio de um atendimento 
médico significativo e personalizado
In this issue of the Portuguese Journal of Public Health, 
Broeiro et al. [1] described the prevalence of multimor-
bidity in Portuguese inpatients, using multiple cut-offs 
for disease counts and for a widely used weighted index 
(the Charlson Comorbidity Index). This paper supple-
ments earlier work documenting the magnitude of mul-
timorbidity in Portuguese primary care [2] and in home-
based hospice care [3]. In this paper, Broeiro et al. [1] 
describe that multimorbidity is common among inpa-
tients and that it becomes more severe and complex when 
participants age. Interestingly, their results seem more 
complex than the traditionally reported S-shaped curve 
of multimorbidity prevalence by age [4]. It is not very 
common to find studies reporting data for the very old 
patients (85+ years of age), and in their study there is a 
decrease in multimorbidity prevalence in this age group. 
One likely explanation is that people with multimorbid-
ity may die before reaching 85 years.
Broeiro et al. [1], once more, bring to our attention the 
magnitude of multimorbidity in Western countries. Mul-
timorbidity becomes common in early midlife [4], it in-
creases mortality [5], it reduces health-related quality of 
life [6, 7], it is a reflex of social inequity [8], and it is as-
sociated with increased societal costs (due to increased 
health care spending, early retirement, and loss of pro-
ductivity for people who are caring for an ill family mem-
ber) [9, 10]. Because of this, health systems need to adapt 
to multimorbidity being the norm, rather than the excep-
tion.
There is now a widespread awareness that interven-
tions developed to improve the care of people with single 
chronic conditions are inadequate for people with multi-
morbidity. Not only do patients and their carers face in-
creased symptom load and disability, but all the disease 
self-management tasks assigned to them (medication, in-
vestigations, clinical appointments, etc.) may be well 
above their capacity [11]. From the clinician perspective, 
common criticisms include that single-illness guidelines 
give rise to conflicting recommendations in patients with 
multimorbidity, and patients with multimorbidity are of-
ten excluded from clinical trials, adding to the uncertain-
ty about how to best manage people with multimorbidity 
[12, 13].
More recently, guidelines specifically developed on 
how to address multimorbidity have been published [14]. 
While they are definitely a step in the right direction, so 
far they more often provide general principles (e.g., “Dis-
cuss with the person the purpose of the approach to care”; 
“Be aware that the management of risk factors for future 
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disease can be a major treatment burden”) or seem diffi-
cult to implement with currently available resources (e.g., 
“Ensure patients with multimorbidity are adequately in-
formed about the expected benefits and harms”; “Review 
the self-management plan to ensure the person does not 
have problems using it”). However, these guidelines must 
go beyond coordinating single-illness clinical practice 
recommendations. They should provide legitimacy to 
multimorbidity management approaches as well as guar-
antee personalised and meaningful health care.
In many ways, it seems that the research that is available 
to clinical guideline panels is still in its infancy. Researchers 
are trying to refine definitions and to find which defini-
tions have better predictive value for mortality or health 
care use [15, 16]. A lot of work is being done to understand 
the causal relationships between social, environmental, be-
havioural, and biological factors and multimorbidity, or in 
trying to find different phenotypes of multimorbidity that 
may predict response to specific interventions. This may 
well explain why many of the interventions which have 
been assessed in randomised trials showed either conflict-
ing results or modest effects [17, 18].
As we learn more about the fundamental research con-
cerning multimorbidity, we are starting to identify which 
interventions and which intervention components seem 
effective in most contexts [19]. There is at least moderate 
quality evidence that primary care interventions such a 
stepped care can improve mental health outcomes in peo-
ple with multimorbidity which includes depression [17, 
18]. Successful organisational interventions seem to in-
clude team-based approaches, systematised approach to 
disease management, and case managers. Successful in-
terventions addressing the clinician-patient relationship 
include identifying which symptoms bother the patient 
most and exploring options for symptom control that are 
acceptable for patients and clinicians. Successful self-
management intervention recognises that not all patients 
are capable of self-care and focuses on establishing with 
the patient what they need to enable self-care [19].
It is not surprising that the evidence is less clear for the 
impact of interventions in mortality, health-related qual-
ity of life, or health care service utilisation [17, 18]. First, 
research in multimorbidity is still exploring many differ-
ent types of interventions. Second, the sample size and 
follow-up duration in most trials is not large enough to 
find differences in mortality, and the heterogeneity of 
multimorbidity seems to preclude the use of condition-
specific health-related quality of life instruments which 
are more sensitive to change than generic instruments 
such as the SF family or the EQ-5D family. Establishing 
modest but clinically significant effects of multimorbidity 
interventions will require large, pragmatic, randomised 
controlled trials or alternative designs such as interrupted 
time series assessing real-world implementation of mul-
timorbidity interventions. Understanding what works in 
which context will require a wide range of qualitative 
studies and subsequent quantitative assessment. Adapta-
tion of health systems to multimorbidity seems to require 
strong research to support effective innovation.
Back to the paper by Broeiro et al. [1] published in this 
issue, its results show that the average patient admitted to 
hospital will have multimorbidity, and the average inpa-
tients aged 65 years or older will have complex multimor-
bidity. This will be directly challenging to all clinicians 
working in hospital wards, surgery theatres, diagnostic 
testing services, liaison services, and outpatient clinics. 
The increase in multimorbidity will trickle to hospice 
care, to social services, and to primary care. A few suc-
cessful interventions for people with multimorbidity have 
been found, leading to modest improvement in impor-
tant patient outcomes at the cost of increased resource 
use. As such, health systems need to adapt, to support 
research efforts, and to innovate if we are to deliver per-
sonalised and meaningful health care.
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